Navigation Links
Lexicon Announces Positive Results of LX4211 Phase 2b Trial For Type 2 Diabetes
Date:6/25/2012

THE WOODLANDS, Texas, June 25, 2012 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that LX4211, an investigational, oral, dual inhibitor of sodium glucose transporters 1 and 2 (SGLT1 and SGLT2), showed substantial, dose-dependent, statistically-significant reductions in hemoglobin A1c (HbA1c) in a Phase 2b trial in patients diagnosed with poorly-controlled type 2 diabetes who were concurrently treated with metformin, an established diabetes therapy. LX4211 treatment also produced significant reductions in body weight and blood pressure. Importantly, LX4211 treatment had a favorable safety profile and was well tolerated in the study.

LX4211, a unique dual inhibitor, reduces the amount of glucose that enters the bloodstream from the gastrointestinal (GI) tract by inhibiting SGLT1, the major transporter responsible for glucose absorption, and enhances glucose excretion in the urine by inhibiting SGLT2, the major transporter responsible for glucose reabsorption by the kidney. Lexicon has previously demonstrated that SGLT1 inhibition by LX4211 increases GLP-1 and PYY, GI hormones associated with glycemic control and appetite.

"New diabetes therapies will need to help patients safely control blood sugar and address other metabolic parameters that play a role in this pervasive disease," said Dr. Arthur Sands, president and chief executive officer of Lexicon. "The positive results obtained when LX4211 is combined with metformin suggest it has the potential to make a meaningful contribution to diabetes care."

In this 12-week dose-ranging study conducted in over 50 centers in the United States, 299 patients with poorly controlled type 2 diabetes on metformin therapy were randomized to receive either LX4211 or placebo. The primary endpoint of the study was the change in HbA1C, a measure of glycemic cont
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
2. Lexicon Pharmaceuticals to present at the Jefferies 2012 Global Healthcare Conference
3. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
4. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 First Quarter Results
5. Lexicon to Provide First Quarter 2012 Financial Results
6. Shire Announces that the US Food and Drug Administration has Responded to its Citizen Petition for Adderall XR and has Approved One Abbreviated New Drug Application for Generic Adderall XR
7. ERT Announces Stockholder Approval of Merger
8. Biodel Announces $18.5 Million Private Placement
9. BioElectronics Corporation Announces Indian Distributors Ecommerce Website
10. Marken Announces Global Advisory Board
11. Community Foundation Announces $2.6 Million In Grants From Centinela Medical Funds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 2015 Research and ... of Jain PharmaBiotech,s new report  "Personalized Medicine ... offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The aim ... to match the right drug to the ... to design the appropriate treatment for a ...
(Date:5/28/2015)... ALEXANDRIA, Va. , May 28, 2015 ... Hoey , RPh, MBA issued the following statement in ... the AARP Public Policy Institute documenting that a number ... "This new report tracks with concerns previously expressed ... Congress to support patient access to essential medications. Moreover, ...
(Date:5/28/2015)... YORK , May 27, 2015 The ... $416 billion in 2014 and with growth of 8% ... three categories out of pocket: directly on expenditures, co-pays ... drug purchases, and on premiums.  The publisher made its ... Expenditures in the United States ...
Breaking Medicine Technology:Global Personalized Medicine Report 2015-2024 - Scientific and Commercial Aspects 2Global Personalized Medicine Report 2015-2024 - Scientific and Commercial Aspects 3NCPA: AARP Drug Pricing Report Reiterates Need for Fair Generic Drug Reimbursements 2Report: U.S. Out-of-Pocket Healthcare Spending Reaches $416 Billion 2Report: U.S. Out-of-Pocket Healthcare Spending Reaches $416 Billion 3
... that normal stem cells can act as the source of ... MEMPHIS, Tenn., Dec. 17 /PRNewswire-USNewswire/ -- ... central question in cancer biology: whether normal stem cells can ... can renew themselves and give rise to mature differentiated cells ...
... PEAK Surgical, Inc., a medical,device company that has ... a,proprietary technology, announced today that the U.S. Food ... clearance to market its,PEAK(R) Surgery System for cutting ... ENT (ear, nose and throat), gynecologic,orthopedic, arthroscopic, spinal ...
Cached Medicine Technology:Molecular Marker Identifies Normal Stem Cells as Intestinal Tumor Source 2Molecular Marker Identifies Normal Stem Cells as Intestinal Tumor Source 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 4
(Date:5/29/2015)... organizational consultant and part-time college professor, Dr. Ben Parks ... be suffering from early dementia. He is embarrassed at ... his uncertain relationship with his wife Addie. , Ben ... and government movers and shakers as they wrestle with ... are being diagnosed with Alzheimer’s, Ben wonders what’s in ...
(Date:5/29/2015)... 29, 2015 The world of dentistry had ... depicted dentists as sadists who dispense pain to people unfortunate ... What's more, when it came to surgeries, people would have ... ­ but that's all back in the 20th Century now. ... practice in the Sheepshead Bay neighborhood of Brooklyn, ...
(Date:5/29/2015)... DISC, a method of behavioral analysis that ... used by companies to improve hiring practices, streamline training, ... an out-of-the-box practice, has now become an integral part ... Society for Human Resource Management found that over 70% ... be an essential part of the hiring process, and ...
(Date:5/29/2015)... Hurst, Texas (PRWEB) May 29, 2015 Testosterone ... in the DFW area, is opening a new center in ... and the rest of the Mid Cities. Located on the ... Line Road in Hurst, the new testosterone center will open ... and women who suffer from low testosterone. , Like TCT’s ...
(Date:5/29/2015)... 2015 Wimbledon Health Partners, the leading ... echocardiogram and NCV testing, is proud to announce ... for EKG interpretation of athletes. , Sudden ... during athletic activity. New findings presented in February have ... improve cardiac safety in athletes. Physiologic adaptations in athletic ...
Breaking Medicine News(10 mins):Health News:‘Forgetful’ Professor Struggles With Dementia in Compelling New Novel 2Health News:Brooklyn Dentist Delivers Comfortable Care Through High Technology 2Health News:Brooklyn Dentist Delivers Comfortable Care Through High Technology 3Health News:Brooklyn Dentist Delivers Comfortable Care Through High Technology 4Health News:PeopleKeys to Air a Follow-up to Their Popular DISC Trainer’s Toolbox Webinar, Featuring All-New Content and Strategies 2Health News:Testosterone Clinics in Colleyville — TCT opens Hurst Location 2Health News:Testosterone Clinics in Colleyville — TCT opens Hurst Location 3Health News:Wimbledon Health Partners Incorporates Updated ‘Seattle Criteria’ for EKG Interpretation of Athletes 2Health News:Wimbledon Health Partners Incorporates Updated ‘Seattle Criteria’ for EKG Interpretation of Athletes 3
... YORK, Nov. 4 Weight Watchers,International, Inc. (NYSE: ... ended September 27, 2008., Third Quarter 2008 Results, ... increased $15.1 million to,$352.6 million, up from $337.5 million ... million associated with the Company,s recent U.K.,value added tax, ...
... 4 As biopharmaceutical,companies focus on line ... (FDC) products have become an,increasingly important segment ... better,understand the development strategies and issues for ... by Best Practices, LLC, with insights available,in ...
... Bulletin Board: NGNM) announced today that it plans to ... 6, 2008., The Company has scheduled a webcast ... November 6, 2008, at 11:00 AM EST. Interested,investors should ... five minutes prior to the call. A replay of ...
... Use of detoxification medications produces noticeable results, study says ... for addiction to heroin or prescription painkillers are less ... extended treatment with a combination of detoxification medications, rather ... Both buprenorphine and naloxone have been shown to be ...
... disease risk, , , TUESDAY, Nov. 4 (HealthDay News) -- Taking ... risk of cancer, new research shows. , However, the good ... either, according to the study, which was published in the ... Medical Association . , "In women at risk of cardiovascular ...
... be Donating a Whole Turkey to the San Francisco Food ... Bank Each Time you Shop Online This Month, ... thanks; a holiday where you spend time with beloved friends,and family ... to,appreciate the things you often take for granted in life. In ...
Cached Medicine News:Health News:Weight Watchers Announces Third Quarter 2008 Results 2Health News:Weight Watchers Announces Third Quarter 2008 Results 3Health News:Weight Watchers Announces Third Quarter 2008 Results 4Health News:Weight Watchers Announces Third Quarter 2008 Results 5Health News:Weight Watchers Announces Third Quarter 2008 Results 6Health News:Weight Watchers Announces Third Quarter 2008 Results 7Health News:Weight Watchers Announces Third Quarter 2008 Results 8Health News:Weight Watchers Announces Third Quarter 2008 Results 9Health News:Weight Watchers Announces Third Quarter 2008 Results 10Health News:Weight Watchers Announces Third Quarter 2008 Results 11Health News:New Study Provides Benchmarks for Fixed-Dose Combination (FDC) Drug Development 2Health News:NeoGenomics Schedules Its Q3 2008 Earnings Release for November 6, 2008 2Health News:Extended Therapy Helps Drug-Addicted Teens 2Health News:Extended Therapy Helps Drug-Addicted Teens 3Health News:Folic Acid and Other B Vitamins Won't Help Prevent Cancer 2Health News:Folic Acid and Other B Vitamins Won't Help Prevent Cancer 3Health News:This Thanksgiving Season, Lifespring Health is Helping You Donate While You Shop 2
Sealing Mat for 384-well PCR Plate, Natural...
MicroAmp Full Plate Covers, which are manufactured from PCR-compatible rubber, are non-sterile, autoclavable and guaranteed reusable up to five times....
Microseal 'M' mats, seals 96-well plates, reusable, pkg of 10...
Easy to pierce, remove using foil stripper...
Medicine Products: